PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function
NCT04656795
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Normal Renal Function
Interventions
DRUG:
MT-7117
Sponsor
Tanabe Pharma America, Inc.